Monopar files for $40M IPO to test chemo side effect drug

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 16, 2019 at 10:12 AM.

  1. #1 cafead, Aug 16, 2019 at 10:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Monopar Therapeutics has filed to raise $40 million through an IPO. The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy.

    article source
     
    Quote

Reply to Thread